Development of nanomedicines for the treatment of Alzheimer’s disease: Raison d’être, strategies, challenges and regulatory aspects-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Development of nanomedicines for the treatment of Alzheimer’s disease: Raison d’être, strategies, challenges and regulatory aspects

Published:2024-07 Issue: Volume:98 Page:102318
ISSN:1568-1637
Container-title:Ageing Research Reviews
language:en
Short-container-title:Ageing Research Reviews

Author:

Mazahir Farhan,Alam Md Imtiyaz,Yadav Awesh Kumar

Funder

Department of Pharmaceuticals, Ministry of Chemicals and Fertilizers, India

National Institute of Pharmaceutical Education and Research Raebareli

Publisher

Elsevier BV

Reference369 articles.

1. Recent advances in green synthesis of silver nanoparticles and their applications: about future directions. a review;Abdelghany;BioNanoScience,2018

2. Considering whether an FDA-regulated product involves the application of nanotechnology;Administration;U. S. Food Drug Adm.,2014

3. A 3D neurovascular microfluidic model consisting of neurons, astrocytes and cerebral endothelial cells as a blood–brain barrier;Adriani;Lab Chip,2017

4. Recent advancements in liposomes targeting strategies to cross blood-brain barrier (BBB) for the treatment of Alzheimer’s disease;Agrawal;J. Control. Release,2017

5. Tumor cells derived-exosomes as angiogenenic agents: possible therapeutic implications;Ahmadi;J. Transl. Med.,2020

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Structural and functional remodeling of neural networks in β-amyloid driven hippocampal hyperactivity;Ageing Research Reviews;2024-11

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP